AngloGold Ashanti Limited vs Citius Pharmaceuticals Inc — how do they compare? AngloGold Ashanti Limited trades at $100.51 (market cap $49.28B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: AngloGold Ashanti Limited is far larger — about 2462.8× Citius Pharmaceuticals Inc's market cap, and AngloGold Ashanti Limited pays a 4.64% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AU | CTXR | |
|---|---|---|
Market Cap | $49.28B | $20.01M |
Sector | Basic Materials | Health |
52-Week High | $128.26 | $1.82 |
52-Week Low | $52.15 | $0.48 |
Enterprise Value | $48.29B | $16.23M |
Dividend Yield | 4.64% | — |
Trailing returns across standard periods
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →